Clinical Trials Browser

Active not recruiting × Nasopharyngeal Carcinoma × Drug Therapy × Clear all

NCT03930498 2025-01-28

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma